Novo Nordisk Files Lawsuit Against Eli Lilly Over "Deceptive" Obesity Drug Advertising Claims
In a significant escalation of the fiercely competitive market for GLP-1 agonist medications, Novo Nordisk...
Knowledge and News for the Global Fight Against Cancer.
In a significant escalation of the fiercely competitive market for GLP-1 agonist medications, Novo Nordisk...
The clinical trial failure of Agios Pharmaceuticals’ investigational drug, tebapivat, marks a significant setback for...
The global biopharmaceutical industry, a beacon of scientific innovation, faces an intricate journey in translating...
The biopharmaceutical sector is witnessing a transformative period marked by aggressive technological adoption, strategic mergers...
Tempus AI has announced its definitive agreement to acquire Personalis, a leading innovator in molecular...
Westlake, CA – July 20, 2026 – Latigo Biotherapeutics, a pioneering biotechnology firm headquartered in...
The biotechnology sector’s resurgence on public markets gained further traction this week with Attovia Therapeutics...
New data emerging from a clinical trial conducted in China have provided what Wall Street...
The pharmaceutical industry stands at a pivotal juncture, with artificial intelligence (AI) heralded as a...
The 2026 American Association of Cancer Research (AACR) Annual Meeting, held in San Diego from...